Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Kidney International|September 1, 2012
Targeting activated mineralocorticoid receptor: Occam's razor revisitedAndrew S BremClinical Science (London, England : 1979)|February 12, 2015
Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular diseaseAndrew S Brem, Rujun GongPhysiological Genomics|January 26, 2019
Role of gut metabolism of adrenal corticosteroids and hypertension: clues gut-cleansing antibiotics give usDavid J Morris, Andrew S BremLife Sciences|February 12, 2008
Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2Rujun Gong, David J Morris, Andrew S BremSteroids|June 25, 2008
Variable expression of 11beta Hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cellsRujun Gong, David J Morris, Andrew S BremThe Journal of Steroid Biochemistry and Molecular Biology|August 31, 2021
Modulation of 11β-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: The glycyrrhetinic acid-like factor (GALF) hypothesisDavid J Morris, Andrew S Brem, Alex OdermattAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2011
Aldosterone-induced fibrosis in the kidney: questions and controversiesAndrew S Brem, David J Morris, Rujun GongSteroids|November 2, 2013
An alternative explanation of hypertension associated with 17α-hydroxylase deficiency syndromeDavid J Morris, Syed A Latif, Andrew S BremSteroids|February 22, 2002
11 beta-Hydroxysteroid dehydrogenase antisense affects vascular contractile response and glucocorticoid metabolismGraham W Souness, Andrew S Brem, David J MorrisPageof 3